Early events in sexual transmission of HIV and SIV and opportunities for interventions

To constrain the growth of the HIV/AIDS pandemic and ultimately end it, effective measures must be developed to prevent sexual mucosal transmission, the major route by which new infections are acquired. I review sexual mucosal transmission of HIV and SIV, with a focus on vaginal transmission in the...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Annual review of medicine 2011-01, Vol.62 (1), p.127-139
1. Verfasser: Haase, Ashley T
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 139
container_issue 1
container_start_page 127
container_title Annual review of medicine
container_volume 62
creator Haase, Ashley T
description To constrain the growth of the HIV/AIDS pandemic and ultimately end it, effective measures must be developed to prevent sexual mucosal transmission, the major route by which new infections are acquired. I review sexual mucosal transmission of HIV and SIV, with a focus on vaginal transmission in the SIV rhesus macaque animal model, and the evidence for small founder populations of infected cells and the local expansion at the portal of entry necessary to establish systemic infection. These early events represent windows of maximum opportunity for interventions to prevent systemic infection. I highlight the paradoxical role the innate immune response plays in actually facilitating transmission, and a novel microbicide strategy that targets this innate response to prevent systemic infection, and I conclude with an agenda for future research that emphasizes mucosal immunology, virology and pathogenesis studies at each anatomic site of entry.
doi_str_mv 10.1146/annurev-med-080709-124959
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_911149180</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2255356581</sourcerecordid><originalsourceid>FETCH-LOGICAL-a496t-2d665b9e245724beb8b44a866301370b92bd15248a65a336c98a980e8b65f2853</originalsourceid><addsrcrecordid>eNqFkT1PwzAQhi0EoqXwF5BhYQr4O_aIqkIrVWIAKjbLaRwpVWoXO6nov8dV0oWF6QY_7935HgDuMHrEmIkn41wX7D7b2jJDEuVIZZgwxdUZGGPOeEaJ-DoHY4SEyBjBagSuYtwghBSl8hKMCEac4RyPwWpmQnOAdm9dG2HtYLQ_nWlgG4yL2zrG2jvoKzhfrKBxJXwfqt_tfGg7V7e1jbDyIWVbG45tUiJeg4vKNNHeDHUCPl9mH9N5tnx7XUyfl5lhSrQZKYXghbKE8ZywwhayYMxIISjCNEeFIkWJOWHSCG4oFWsljZLIykLwikhOJ-Ch77sL_ruzsdVp57VtGuOs76JWOB1MYYn-JSVDlOWc5om8_0NufBdc-kaCZE7T7UiCVA-tg48x2ErvQr014aAx0kdJepCkkyTdS9K9pJS9HQZ0xfH1lDxZob-kvo-T</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>848731052</pqid></control><display><type>article</type><title>Early events in sexual transmission of HIV and SIV and opportunities for interventions</title><source>Annual Reviews Complete A-Z List</source><source>MEDLINE</source><creator>Haase, Ashley T</creator><creatorcontrib>Haase, Ashley T</creatorcontrib><description>To constrain the growth of the HIV/AIDS pandemic and ultimately end it, effective measures must be developed to prevent sexual mucosal transmission, the major route by which new infections are acquired. I review sexual mucosal transmission of HIV and SIV, with a focus on vaginal transmission in the SIV rhesus macaque animal model, and the evidence for small founder populations of infected cells and the local expansion at the portal of entry necessary to establish systemic infection. These early events represent windows of maximum opportunity for interventions to prevent systemic infection. I highlight the paradoxical role the innate immune response plays in actually facilitating transmission, and a novel microbicide strategy that targets this innate response to prevent systemic infection, and I conclude with an agenda for future research that emphasizes mucosal immunology, virology and pathogenesis studies at each anatomic site of entry.</description><identifier>ISSN: 0066-4219</identifier><identifier>EISSN: 1545-326X</identifier><identifier>DOI: 10.1146/annurev-med-080709-124959</identifier><identifier>PMID: 21054171</identifier><language>eng</language><publisher>United States: Annual Reviews, Inc</publisher><subject>Acquired immune deficiency syndrome ; AIDS ; AIDS Vaccines - immunology ; AIDS Vaccines - therapeutic use ; Animals ; Antiviral Agents - therapeutic use ; Cells ; Disease Models, Animal ; Disease transmission ; Female ; HIV ; HIV Infections - immunology ; HIV Infections - prevention &amp; control ; HIV Infections - transmission ; Human immunodeficiency virus ; Humans ; Immunology ; Intervention ; Laurates - therapeutic use ; Macaca mulatta ; Male ; Monoglycerides - therapeutic use ; Mucous Membrane - immunology ; Mucous Membrane - virology ; SAIDS Vaccines - immunology ; SAIDS Vaccines - therapeutic use ; Simian Acquired Immunodeficiency Syndrome - immunology ; Simian Acquired Immunodeficiency Syndrome - prevention &amp; control ; Simian Acquired Immunodeficiency Syndrome - transmission ; Simian immunodeficiency virus ; Surface-Active Agents - therapeutic use ; Treatment Outcome ; Vagina - virology</subject><ispartof>Annual review of medicine, 2011-01, Vol.62 (1), p.127-139</ispartof><rights>Copyright Annual Reviews, Inc. 2011</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-a496t-2d665b9e245724beb8b44a866301370b92bd15248a65a336c98a980e8b65f2853</citedby><cites>FETCH-LOGICAL-a496t-2d665b9e245724beb8b44a866301370b92bd15248a65a336c98a980e8b65f2853</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,4182,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/21054171$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Haase, Ashley T</creatorcontrib><title>Early events in sexual transmission of HIV and SIV and opportunities for interventions</title><title>Annual review of medicine</title><addtitle>Annu Rev Med</addtitle><description>To constrain the growth of the HIV/AIDS pandemic and ultimately end it, effective measures must be developed to prevent sexual mucosal transmission, the major route by which new infections are acquired. I review sexual mucosal transmission of HIV and SIV, with a focus on vaginal transmission in the SIV rhesus macaque animal model, and the evidence for small founder populations of infected cells and the local expansion at the portal of entry necessary to establish systemic infection. These early events represent windows of maximum opportunity for interventions to prevent systemic infection. I highlight the paradoxical role the innate immune response plays in actually facilitating transmission, and a novel microbicide strategy that targets this innate response to prevent systemic infection, and I conclude with an agenda for future research that emphasizes mucosal immunology, virology and pathogenesis studies at each anatomic site of entry.</description><subject>Acquired immune deficiency syndrome</subject><subject>AIDS</subject><subject>AIDS Vaccines - immunology</subject><subject>AIDS Vaccines - therapeutic use</subject><subject>Animals</subject><subject>Antiviral Agents - therapeutic use</subject><subject>Cells</subject><subject>Disease Models, Animal</subject><subject>Disease transmission</subject><subject>Female</subject><subject>HIV</subject><subject>HIV Infections - immunology</subject><subject>HIV Infections - prevention &amp; control</subject><subject>HIV Infections - transmission</subject><subject>Human immunodeficiency virus</subject><subject>Humans</subject><subject>Immunology</subject><subject>Intervention</subject><subject>Laurates - therapeutic use</subject><subject>Macaca mulatta</subject><subject>Male</subject><subject>Monoglycerides - therapeutic use</subject><subject>Mucous Membrane - immunology</subject><subject>Mucous Membrane - virology</subject><subject>SAIDS Vaccines - immunology</subject><subject>SAIDS Vaccines - therapeutic use</subject><subject>Simian Acquired Immunodeficiency Syndrome - immunology</subject><subject>Simian Acquired Immunodeficiency Syndrome - prevention &amp; control</subject><subject>Simian Acquired Immunodeficiency Syndrome - transmission</subject><subject>Simian immunodeficiency virus</subject><subject>Surface-Active Agents - therapeutic use</subject><subject>Treatment Outcome</subject><subject>Vagina - virology</subject><issn>0066-4219</issn><issn>1545-326X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2011</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkT1PwzAQhi0EoqXwF5BhYQr4O_aIqkIrVWIAKjbLaRwpVWoXO6nov8dV0oWF6QY_7935HgDuMHrEmIkn41wX7D7b2jJDEuVIZZgwxdUZGGPOeEaJ-DoHY4SEyBjBagSuYtwghBSl8hKMCEac4RyPwWpmQnOAdm9dG2HtYLQ_nWlgG4yL2zrG2jvoKzhfrKBxJXwfqt_tfGg7V7e1jbDyIWVbG45tUiJeg4vKNNHeDHUCPl9mH9N5tnx7XUyfl5lhSrQZKYXghbKE8ZywwhayYMxIISjCNEeFIkWJOWHSCG4oFWsljZLIykLwikhOJ-Ch77sL_ruzsdVp57VtGuOs76JWOB1MYYn-JSVDlOWc5om8_0NufBdc-kaCZE7T7UiCVA-tg48x2ErvQr014aAx0kdJepCkkyTdS9K9pJS9HQZ0xfH1lDxZob-kvo-T</recordid><startdate>20110101</startdate><enddate>20110101</enddate><creator>Haase, Ashley T</creator><general>Annual Reviews, Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QP</scope><scope>7T5</scope><scope>7TO</scope><scope>7U9</scope><scope>8FD</scope><scope>FR3</scope><scope>H94</scope><scope>K9.</scope><scope>P64</scope><scope>RC3</scope><scope>7X8</scope></search><sort><creationdate>20110101</creationdate><title>Early events in sexual transmission of HIV and SIV and opportunities for interventions</title><author>Haase, Ashley T</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-a496t-2d665b9e245724beb8b44a866301370b92bd15248a65a336c98a980e8b65f2853</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2011</creationdate><topic>Acquired immune deficiency syndrome</topic><topic>AIDS</topic><topic>AIDS Vaccines - immunology</topic><topic>AIDS Vaccines - therapeutic use</topic><topic>Animals</topic><topic>Antiviral Agents - therapeutic use</topic><topic>Cells</topic><topic>Disease Models, Animal</topic><topic>Disease transmission</topic><topic>Female</topic><topic>HIV</topic><topic>HIV Infections - immunology</topic><topic>HIV Infections - prevention &amp; control</topic><topic>HIV Infections - transmission</topic><topic>Human immunodeficiency virus</topic><topic>Humans</topic><topic>Immunology</topic><topic>Intervention</topic><topic>Laurates - therapeutic use</topic><topic>Macaca mulatta</topic><topic>Male</topic><topic>Monoglycerides - therapeutic use</topic><topic>Mucous Membrane - immunology</topic><topic>Mucous Membrane - virology</topic><topic>SAIDS Vaccines - immunology</topic><topic>SAIDS Vaccines - therapeutic use</topic><topic>Simian Acquired Immunodeficiency Syndrome - immunology</topic><topic>Simian Acquired Immunodeficiency Syndrome - prevention &amp; control</topic><topic>Simian Acquired Immunodeficiency Syndrome - transmission</topic><topic>Simian immunodeficiency virus</topic><topic>Surface-Active Agents - therapeutic use</topic><topic>Treatment Outcome</topic><topic>Vagina - virology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Haase, Ashley T</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Calcium &amp; Calcified Tissue Abstracts</collection><collection>Immunology Abstracts</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Annual review of medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Haase, Ashley T</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Early events in sexual transmission of HIV and SIV and opportunities for interventions</atitle><jtitle>Annual review of medicine</jtitle><addtitle>Annu Rev Med</addtitle><date>2011-01-01</date><risdate>2011</risdate><volume>62</volume><issue>1</issue><spage>127</spage><epage>139</epage><pages>127-139</pages><issn>0066-4219</issn><eissn>1545-326X</eissn><abstract>To constrain the growth of the HIV/AIDS pandemic and ultimately end it, effective measures must be developed to prevent sexual mucosal transmission, the major route by which new infections are acquired. I review sexual mucosal transmission of HIV and SIV, with a focus on vaginal transmission in the SIV rhesus macaque animal model, and the evidence for small founder populations of infected cells and the local expansion at the portal of entry necessary to establish systemic infection. These early events represent windows of maximum opportunity for interventions to prevent systemic infection. I highlight the paradoxical role the innate immune response plays in actually facilitating transmission, and a novel microbicide strategy that targets this innate response to prevent systemic infection, and I conclude with an agenda for future research that emphasizes mucosal immunology, virology and pathogenesis studies at each anatomic site of entry.</abstract><cop>United States</cop><pub>Annual Reviews, Inc</pub><pmid>21054171</pmid><doi>10.1146/annurev-med-080709-124959</doi><tpages>13</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0066-4219
ispartof Annual review of medicine, 2011-01, Vol.62 (1), p.127-139
issn 0066-4219
1545-326X
language eng
recordid cdi_proquest_miscellaneous_911149180
source Annual Reviews Complete A-Z List; MEDLINE
subjects Acquired immune deficiency syndrome
AIDS
AIDS Vaccines - immunology
AIDS Vaccines - therapeutic use
Animals
Antiviral Agents - therapeutic use
Cells
Disease Models, Animal
Disease transmission
Female
HIV
HIV Infections - immunology
HIV Infections - prevention & control
HIV Infections - transmission
Human immunodeficiency virus
Humans
Immunology
Intervention
Laurates - therapeutic use
Macaca mulatta
Male
Monoglycerides - therapeutic use
Mucous Membrane - immunology
Mucous Membrane - virology
SAIDS Vaccines - immunology
SAIDS Vaccines - therapeutic use
Simian Acquired Immunodeficiency Syndrome - immunology
Simian Acquired Immunodeficiency Syndrome - prevention & control
Simian Acquired Immunodeficiency Syndrome - transmission
Simian immunodeficiency virus
Surface-Active Agents - therapeutic use
Treatment Outcome
Vagina - virology
title Early events in sexual transmission of HIV and SIV and opportunities for interventions
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-06T21%3A32%3A20IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Early%20events%20in%20sexual%20transmission%20of%20HIV%20and%20SIV%20and%20opportunities%20for%20interventions&rft.jtitle=Annual%20review%20of%20medicine&rft.au=Haase,%20Ashley%20T&rft.date=2011-01-01&rft.volume=62&rft.issue=1&rft.spage=127&rft.epage=139&rft.pages=127-139&rft.issn=0066-4219&rft.eissn=1545-326X&rft_id=info:doi/10.1146/annurev-med-080709-124959&rft_dat=%3Cproquest_cross%3E2255356581%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=848731052&rft_id=info:pmid/21054171&rfr_iscdi=true